C4 THERAPEUTICS INC (CCCC)
C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by J
Office
CS Hotline: +852 3018 4526
Trading days: 24 hours
Non-trading days: 9:00-18:00
Email: cs@usmarthk.com
Address: 26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp: +852 5989 2641
Physical Store
